Global Primary Hyperoxaluria Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Primary Hyperoxaluria Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Primary Hyperoxaluria Drug industry chain, the market status of Hospital (ALLN-230, DCR-PHXC), Clinic (ALLN-230, DCR-PHXC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Primary Hyperoxaluria Drug.
Regionally, the report analyzes the Primary Hyperoxaluria Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Primary Hyperoxaluria Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Primary Hyperoxaluria Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Primary Hyperoxaluria Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., ALLN-230, DCR-PHXC).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Primary Hyperoxaluria Drug market.
Regional Analysis: The report involves examining the Primary Hyperoxaluria Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Primary Hyperoxaluria Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Primary Hyperoxaluria Drug:
Company Analysis: Report covers individual Primary Hyperoxaluria Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Primary Hyperoxaluria Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Primary Hyperoxaluria Drug. It assesses the current state, advancements, and potential future developments in Primary Hyperoxaluria Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Primary Hyperoxaluria Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Primary Hyperoxaluria Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Primary Hyperoxaluria Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Primary Hyperoxaluria Drug, with price, sales, revenue and global market share of Primary Hyperoxaluria Drug from 2019 to 2024.
Chapter 3, the Primary Hyperoxaluria Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primary Hyperoxaluria Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Primary Hyperoxaluria Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Primary Hyperoxaluria Drug.
Chapter 14 and 15, to describe Primary Hyperoxaluria Drug sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Primary Hyperoxaluria Drug industry chain, the market status of Hospital (ALLN-230, DCR-PHXC), Clinic (ALLN-230, DCR-PHXC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Primary Hyperoxaluria Drug.
Regionally, the report analyzes the Primary Hyperoxaluria Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Primary Hyperoxaluria Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Primary Hyperoxaluria Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Primary Hyperoxaluria Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., ALLN-230, DCR-PHXC).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Primary Hyperoxaluria Drug market.
Regional Analysis: The report involves examining the Primary Hyperoxaluria Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Primary Hyperoxaluria Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Primary Hyperoxaluria Drug:
Company Analysis: Report covers individual Primary Hyperoxaluria Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Primary Hyperoxaluria Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Primary Hyperoxaluria Drug. It assesses the current state, advancements, and potential future developments in Primary Hyperoxaluria Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Primary Hyperoxaluria Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Primary Hyperoxaluria Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- ALLN-230
- DCR-PHXC
- ALN-GO1
- Others
- Hospital
- Clinic
- Others
- Allena Pharmaceuticals Inc
- Alnylam Pharmaceuticals Inc
- Dicerna Pharmaceuticals Inc
- Intellia Therapeutics Inc
- OxThera AB
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Primary Hyperoxaluria Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Primary Hyperoxaluria Drug, with price, sales, revenue and global market share of Primary Hyperoxaluria Drug from 2019 to 2024.
Chapter 3, the Primary Hyperoxaluria Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Primary Hyperoxaluria Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Primary Hyperoxaluria Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Primary Hyperoxaluria Drug.
Chapter 14 and 15, to describe Primary Hyperoxaluria Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Primary Hyperoxaluria Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Primary Hyperoxaluria Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 ALLN-230
1.3.3 DCR-PHXC
1.3.4 ALN-GO1
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Primary Hyperoxaluria Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Primary Hyperoxaluria Drug Market Size & Forecast
1.5.1 Global Primary Hyperoxaluria Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Primary Hyperoxaluria Drug Sales Quantity (2019-2030)
1.5.3 Global Primary Hyperoxaluria Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Allena Pharmaceuticals Inc
2.1.1 Allena Pharmaceuticals Inc Details
2.1.2 Allena Pharmaceuticals Inc Major Business
2.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
2.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Allena Pharmaceuticals Inc Recent Developments/Updates
2.2 Alnylam Pharmaceuticals Inc
2.2.1 Alnylam Pharmaceuticals Inc Details
2.2.2 Alnylam Pharmaceuticals Inc Major Business
2.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
2.2.4 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Alnylam Pharmaceuticals Inc Recent Developments/Updates
2.3 Dicerna Pharmaceuticals Inc
2.3.1 Dicerna Pharmaceuticals Inc Details
2.3.2 Dicerna Pharmaceuticals Inc Major Business
2.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
2.3.4 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Dicerna Pharmaceuticals Inc Recent Developments/Updates
2.4 Intellia Therapeutics Inc
2.4.1 Intellia Therapeutics Inc Details
2.4.2 Intellia Therapeutics Inc Major Business
2.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product and Services
2.4.4 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Intellia Therapeutics Inc Recent Developments/Updates
2.5 OxThera AB
2.5.1 OxThera AB Details
2.5.2 OxThera AB Major Business
2.5.3 OxThera AB Primary Hyperoxaluria Drug Product and Services
2.5.4 OxThera AB Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 OxThera AB Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PRIMARY HYPEROXALURIA DRUG BY MANUFACTURER
3.1 Global Primary Hyperoxaluria Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Primary Hyperoxaluria Drug Revenue by Manufacturer (2019-2024)
3.3 Global Primary Hyperoxaluria Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Primary Hyperoxaluria Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Primary Hyperoxaluria Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Primary Hyperoxaluria Drug Manufacturer Market Share in 2023
3.5 Primary Hyperoxaluria Drug Market: Overall Company Footprint Analysis
3.5.1 Primary Hyperoxaluria Drug Market: Region Footprint
3.5.2 Primary Hyperoxaluria Drug Market: Company Product Type Footprint
3.5.3 Primary Hyperoxaluria Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Primary Hyperoxaluria Drug Market Size by Region
4.1.1 Global Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Primary Hyperoxaluria Drug Consumption Value by Region (2019-2030)
4.1.3 Global Primary Hyperoxaluria Drug Average Price by Region (2019-2030)
4.2 North America Primary Hyperoxaluria Drug Consumption Value (2019-2030)
4.3 Europe Primary Hyperoxaluria Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Primary Hyperoxaluria Drug Consumption Value (2019-2030)
4.5 South America Primary Hyperoxaluria Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Primary Hyperoxaluria Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
5.2 Global Primary Hyperoxaluria Drug Consumption Value by Type (2019-2030)
5.3 Global Primary Hyperoxaluria Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
6.2 Global Primary Hyperoxaluria Drug Consumption Value by Application (2019-2030)
6.3 Global Primary Hyperoxaluria Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
7.2 North America Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
7.3 North America Primary Hyperoxaluria Drug Market Size by Country
7.3.1 North America Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Primary Hyperoxaluria Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
8.2 Europe Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
8.3 Europe Primary Hyperoxaluria Drug Market Size by Country
8.3.1 Europe Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Primary Hyperoxaluria Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Primary Hyperoxaluria Drug Market Size by Region
9.3.1 Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Primary Hyperoxaluria Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
10.2 South America Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
10.3 South America Primary Hyperoxaluria Drug Market Size by Country
10.3.1 South America Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Primary Hyperoxaluria Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Primary Hyperoxaluria Drug Market Size by Country
11.3.1 Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Primary Hyperoxaluria Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Primary Hyperoxaluria Drug Market Drivers
12.2 Primary Hyperoxaluria Drug Market Restraints
12.3 Primary Hyperoxaluria Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Primary Hyperoxaluria Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Primary Hyperoxaluria Drug
13.3 Primary Hyperoxaluria Drug Production Process
13.4 Primary Hyperoxaluria Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Primary Hyperoxaluria Drug Typical Distributors
14.3 Primary Hyperoxaluria Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Primary Hyperoxaluria Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Primary Hyperoxaluria Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 ALLN-230
1.3.3 DCR-PHXC
1.3.4 ALN-GO1
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Primary Hyperoxaluria Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Primary Hyperoxaluria Drug Market Size & Forecast
1.5.1 Global Primary Hyperoxaluria Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Primary Hyperoxaluria Drug Sales Quantity (2019-2030)
1.5.3 Global Primary Hyperoxaluria Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Allena Pharmaceuticals Inc
2.1.1 Allena Pharmaceuticals Inc Details
2.1.2 Allena Pharmaceuticals Inc Major Business
2.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
2.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Allena Pharmaceuticals Inc Recent Developments/Updates
2.2 Alnylam Pharmaceuticals Inc
2.2.1 Alnylam Pharmaceuticals Inc Details
2.2.2 Alnylam Pharmaceuticals Inc Major Business
2.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
2.2.4 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Alnylam Pharmaceuticals Inc Recent Developments/Updates
2.3 Dicerna Pharmaceuticals Inc
2.3.1 Dicerna Pharmaceuticals Inc Details
2.3.2 Dicerna Pharmaceuticals Inc Major Business
2.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
2.3.4 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Dicerna Pharmaceuticals Inc Recent Developments/Updates
2.4 Intellia Therapeutics Inc
2.4.1 Intellia Therapeutics Inc Details
2.4.2 Intellia Therapeutics Inc Major Business
2.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product and Services
2.4.4 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Intellia Therapeutics Inc Recent Developments/Updates
2.5 OxThera AB
2.5.1 OxThera AB Details
2.5.2 OxThera AB Major Business
2.5.3 OxThera AB Primary Hyperoxaluria Drug Product and Services
2.5.4 OxThera AB Primary Hyperoxaluria Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 OxThera AB Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PRIMARY HYPEROXALURIA DRUG BY MANUFACTURER
3.1 Global Primary Hyperoxaluria Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Primary Hyperoxaluria Drug Revenue by Manufacturer (2019-2024)
3.3 Global Primary Hyperoxaluria Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Primary Hyperoxaluria Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Primary Hyperoxaluria Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Primary Hyperoxaluria Drug Manufacturer Market Share in 2023
3.5 Primary Hyperoxaluria Drug Market: Overall Company Footprint Analysis
3.5.1 Primary Hyperoxaluria Drug Market: Region Footprint
3.5.2 Primary Hyperoxaluria Drug Market: Company Product Type Footprint
3.5.3 Primary Hyperoxaluria Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Primary Hyperoxaluria Drug Market Size by Region
4.1.1 Global Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Primary Hyperoxaluria Drug Consumption Value by Region (2019-2030)
4.1.3 Global Primary Hyperoxaluria Drug Average Price by Region (2019-2030)
4.2 North America Primary Hyperoxaluria Drug Consumption Value (2019-2030)
4.3 Europe Primary Hyperoxaluria Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Primary Hyperoxaluria Drug Consumption Value (2019-2030)
4.5 South America Primary Hyperoxaluria Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Primary Hyperoxaluria Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
5.2 Global Primary Hyperoxaluria Drug Consumption Value by Type (2019-2030)
5.3 Global Primary Hyperoxaluria Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
6.2 Global Primary Hyperoxaluria Drug Consumption Value by Application (2019-2030)
6.3 Global Primary Hyperoxaluria Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
7.2 North America Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
7.3 North America Primary Hyperoxaluria Drug Market Size by Country
7.3.1 North America Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Primary Hyperoxaluria Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
8.2 Europe Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
8.3 Europe Primary Hyperoxaluria Drug Market Size by Country
8.3.1 Europe Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Primary Hyperoxaluria Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Primary Hyperoxaluria Drug Market Size by Region
9.3.1 Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Primary Hyperoxaluria Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
10.2 South America Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
10.3 South America Primary Hyperoxaluria Drug Market Size by Country
10.3.1 South America Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Primary Hyperoxaluria Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Primary Hyperoxaluria Drug Market Size by Country
11.3.1 Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Primary Hyperoxaluria Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Primary Hyperoxaluria Drug Market Drivers
12.2 Primary Hyperoxaluria Drug Market Restraints
12.3 Primary Hyperoxaluria Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Primary Hyperoxaluria Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Primary Hyperoxaluria Drug
13.3 Primary Hyperoxaluria Drug Production Process
13.4 Primary Hyperoxaluria Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Primary Hyperoxaluria Drug Typical Distributors
14.3 Primary Hyperoxaluria Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Primary Hyperoxaluria Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Primary Hyperoxaluria Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Allena Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 4. Allena Pharmaceuticals Inc Major Business
Table 5. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
Table 6. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Allena Pharmaceuticals Inc Recent Developments/Updates
Table 8. Alnylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 9. Alnylam Pharmaceuticals Inc Major Business
Table 10. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
Table 11. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Alnylam Pharmaceuticals Inc Recent Developments/Updates
Table 13. Dicerna Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 14. Dicerna Pharmaceuticals Inc Major Business
Table 15. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
Table 16. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Dicerna Pharmaceuticals Inc Recent Developments/Updates
Table 18. Intellia Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 19. Intellia Therapeutics Inc Major Business
Table 20. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product and Services
Table 21. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Intellia Therapeutics Inc Recent Developments/Updates
Table 23. OxThera AB Basic Information, Manufacturing Base and Competitors
Table 24. OxThera AB Major Business
Table 25. OxThera AB Primary Hyperoxaluria Drug Product and Services
Table 26. OxThera AB Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. OxThera AB Recent Developments/Updates
Table 28. Global Primary Hyperoxaluria Drug Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 29. Global Primary Hyperoxaluria Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Primary Hyperoxaluria Drug Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 31. Market Position of Manufacturers in Primary Hyperoxaluria Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Primary Hyperoxaluria Drug Production Site of Key Manufacturer
Table 33. Primary Hyperoxaluria Drug Market: Company Product Type Footprint
Table 34. Primary Hyperoxaluria Drug Market: Company Product Application Footprint
Table 35. Primary Hyperoxaluria Drug New Market Entrants and Barriers to Market Entry
Table 36. Primary Hyperoxaluria Drug Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 38. Global Primary Hyperoxaluria Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 39. Global Primary Hyperoxaluria Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Primary Hyperoxaluria Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Primary Hyperoxaluria Drug Average Price by Region (2019-2024) & (USD/Pcs)
Table 42. Global Primary Hyperoxaluria Drug Average Price by Region (2025-2030) & (USD/Pcs)
Table 43. Global Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 44. Global Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 45. Global Primary Hyperoxaluria Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Primary Hyperoxaluria Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Primary Hyperoxaluria Drug Average Price by Type (2019-2024) & (USD/Pcs)
Table 48. Global Primary Hyperoxaluria Drug Average Price by Type (2025-2030) & (USD/Pcs)
Table 49. Global Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 50. Global Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 51. Global Primary Hyperoxaluria Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 52. Global Primary Hyperoxaluria Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 53. Global Primary Hyperoxaluria Drug Average Price by Application (2019-2024) & (USD/Pcs)
Table 54. Global Primary Hyperoxaluria Drug Average Price by Application (2025-2030) & (USD/Pcs)
Table 55. North America Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 56. North America Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 57. North America Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 58. North America Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 59. North America Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 60. North America Primary Hyperoxaluria Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 61. North America Primary Hyperoxaluria Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Primary Hyperoxaluria Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 64. Europe Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 65. Europe Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 66. Europe Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 67. Europe Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 68. Europe Primary Hyperoxaluria Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 69. Europe Primary Hyperoxaluria Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Primary Hyperoxaluria Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 72. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 73. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 74. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 75. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 76. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 77. Asia-Pacific Primary Hyperoxaluria Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Primary Hyperoxaluria Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 80. South America Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 81. South America Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 82. South America Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 83. South America Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 84. South America Primary Hyperoxaluria Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 85. South America Primary Hyperoxaluria Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Primary Hyperoxaluria Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 88. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 89. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 90. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 91. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 92. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 93. Middle East & Africa Primary Hyperoxaluria Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Primary Hyperoxaluria Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Primary Hyperoxaluria Drug Raw Material
Table 96. Key Manufacturers of Primary Hyperoxaluria Drug Raw Materials
Table 97. Primary Hyperoxaluria Drug Typical Distributors
Table 98. Primary Hyperoxaluria Drug Typical Customers
Table 1. Global Primary Hyperoxaluria Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Primary Hyperoxaluria Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Allena Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 4. Allena Pharmaceuticals Inc Major Business
Table 5. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
Table 6. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Allena Pharmaceuticals Inc Recent Developments/Updates
Table 8. Alnylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 9. Alnylam Pharmaceuticals Inc Major Business
Table 10. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
Table 11. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Alnylam Pharmaceuticals Inc Recent Developments/Updates
Table 13. Dicerna Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 14. Dicerna Pharmaceuticals Inc Major Business
Table 15. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Product and Services
Table 16. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Dicerna Pharmaceuticals Inc Recent Developments/Updates
Table 18. Intellia Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 19. Intellia Therapeutics Inc Major Business
Table 20. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Product and Services
Table 21. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Intellia Therapeutics Inc Recent Developments/Updates
Table 23. OxThera AB Basic Information, Manufacturing Base and Competitors
Table 24. OxThera AB Major Business
Table 25. OxThera AB Primary Hyperoxaluria Drug Product and Services
Table 26. OxThera AB Primary Hyperoxaluria Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. OxThera AB Recent Developments/Updates
Table 28. Global Primary Hyperoxaluria Drug Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 29. Global Primary Hyperoxaluria Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global Primary Hyperoxaluria Drug Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 31. Market Position of Manufacturers in Primary Hyperoxaluria Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 32. Head Office and Primary Hyperoxaluria Drug Production Site of Key Manufacturer
Table 33. Primary Hyperoxaluria Drug Market: Company Product Type Footprint
Table 34. Primary Hyperoxaluria Drug Market: Company Product Application Footprint
Table 35. Primary Hyperoxaluria Drug New Market Entrants and Barriers to Market Entry
Table 36. Primary Hyperoxaluria Drug Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 38. Global Primary Hyperoxaluria Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 39. Global Primary Hyperoxaluria Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 40. Global Primary Hyperoxaluria Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 41. Global Primary Hyperoxaluria Drug Average Price by Region (2019-2024) & (USD/Pcs)
Table 42. Global Primary Hyperoxaluria Drug Average Price by Region (2025-2030) & (USD/Pcs)
Table 43. Global Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 44. Global Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 45. Global Primary Hyperoxaluria Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 46. Global Primary Hyperoxaluria Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 47. Global Primary Hyperoxaluria Drug Average Price by Type (2019-2024) & (USD/Pcs)
Table 48. Global Primary Hyperoxaluria Drug Average Price by Type (2025-2030) & (USD/Pcs)
Table 49. Global Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 50. Global Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 51. Global Primary Hyperoxaluria Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 52. Global Primary Hyperoxaluria Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 53. Global Primary Hyperoxaluria Drug Average Price by Application (2019-2024) & (USD/Pcs)
Table 54. Global Primary Hyperoxaluria Drug Average Price by Application (2025-2030) & (USD/Pcs)
Table 55. North America Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 56. North America Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 57. North America Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 58. North America Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 59. North America Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 60. North America Primary Hyperoxaluria Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 61. North America Primary Hyperoxaluria Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 62. North America Primary Hyperoxaluria Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 63. Europe Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 64. Europe Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 65. Europe Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 66. Europe Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 67. Europe Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 68. Europe Primary Hyperoxaluria Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 69. Europe Primary Hyperoxaluria Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Primary Hyperoxaluria Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 72. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 73. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 74. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 75. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 76. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 77. Asia-Pacific Primary Hyperoxaluria Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 78. Asia-Pacific Primary Hyperoxaluria Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 79. South America Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 80. South America Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 81. South America Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 82. South America Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 83. South America Primary Hyperoxaluria Drug Sales Quantity by Country (2019-2024) & (K Pcs)
Table 84. South America Primary Hyperoxaluria Drug Sales Quantity by Country (2025-2030) & (K Pcs)
Table 85. South America Primary Hyperoxaluria Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 86. South America Primary Hyperoxaluria Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 87. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Type (2019-2024) & (K Pcs)
Table 88. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Type (2025-2030) & (K Pcs)
Table 89. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Application (2019-2024) & (K Pcs)
Table 90. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Application (2025-2030) & (K Pcs)
Table 91. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Region (2019-2024) & (K Pcs)
Table 92. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity by Region (2025-2030) & (K Pcs)
Table 93. Middle East & Africa Primary Hyperoxaluria Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 94. Middle East & Africa Primary Hyperoxaluria Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 95. Primary Hyperoxaluria Drug Raw Material
Table 96. Key Manufacturers of Primary Hyperoxaluria Drug Raw Materials
Table 97. Primary Hyperoxaluria Drug Typical Distributors
Table 98. Primary Hyperoxaluria Drug Typical Customers
LIST OF FIGURES
Figure 1. Primary Hyperoxaluria Drug Picture
Figure 2. Global Primary Hyperoxaluria Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Type in 2023
Figure 4. ALLN-230 Examples
Figure 5. DCR-PHXC Examples
Figure 6. ALN-GO1 Examples
Figure 7. Others Examples
Figure 8. Global Primary Hyperoxaluria Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Primary Hyperoxaluria Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Primary Hyperoxaluria Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Primary Hyperoxaluria Drug Sales Quantity (2019-2030) & (K Pcs)
Figure 16. Global Primary Hyperoxaluria Drug Average Price (2019-2030) & (USD/Pcs)
Figure 17. Global Primary Hyperoxaluria Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Primary Hyperoxaluria Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Primary Hyperoxaluria Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Primary Hyperoxaluria Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Primary Hyperoxaluria Drug Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Primary Hyperoxaluria Drug Average Price by Type (2019-2030) & (USD/Pcs)
Figure 32. Global Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Primary Hyperoxaluria Drug Average Price by Application (2019-2030) & (USD/Pcs)
Figure 35. North America Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Primary Hyperoxaluria Drug Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Primary Hyperoxaluria Drug Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Primary Hyperoxaluria Drug Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Primary Hyperoxaluria Drug Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Primary Hyperoxaluria Drug Consumption Value Market Share by Region (2019-2030)
Figure 55. China Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Primary Hyperoxaluria Drug Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Primary Hyperoxaluria Drug Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Primary Hyperoxaluria Drug Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Primary Hyperoxaluria Drug Market Drivers
Figure 76. Primary Hyperoxaluria Drug Market Restraints
Figure 77. Primary Hyperoxaluria Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Primary Hyperoxaluria Drug in 2023
Figure 80. Manufacturing Process Analysis of Primary Hyperoxaluria Drug
Figure 81. Primary Hyperoxaluria Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Primary Hyperoxaluria Drug Picture
Figure 2. Global Primary Hyperoxaluria Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Type in 2023
Figure 4. ALLN-230 Examples
Figure 5. DCR-PHXC Examples
Figure 6. ALN-GO1 Examples
Figure 7. Others Examples
Figure 8. Global Primary Hyperoxaluria Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Primary Hyperoxaluria Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Primary Hyperoxaluria Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Primary Hyperoxaluria Drug Sales Quantity (2019-2030) & (K Pcs)
Figure 16. Global Primary Hyperoxaluria Drug Average Price (2019-2030) & (USD/Pcs)
Figure 17. Global Primary Hyperoxaluria Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Primary Hyperoxaluria Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Primary Hyperoxaluria Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Primary Hyperoxaluria Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Primary Hyperoxaluria Drug Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Primary Hyperoxaluria Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Primary Hyperoxaluria Drug Average Price by Type (2019-2030) & (USD/Pcs)
Figure 32. Global Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Primary Hyperoxaluria Drug Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Primary Hyperoxaluria Drug Average Price by Application (2019-2030) & (USD/Pcs)
Figure 35. North America Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Primary Hyperoxaluria Drug Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Primary Hyperoxaluria Drug Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Primary Hyperoxaluria Drug Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Primary Hyperoxaluria Drug Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Primary Hyperoxaluria Drug Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Primary Hyperoxaluria Drug Consumption Value Market Share by Region (2019-2030)
Figure 55. China Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Primary Hyperoxaluria Drug Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Primary Hyperoxaluria Drug Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Primary Hyperoxaluria Drug Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Primary Hyperoxaluria Drug Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Primary Hyperoxaluria Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Primary Hyperoxaluria Drug Market Drivers
Figure 76. Primary Hyperoxaluria Drug Market Restraints
Figure 77. Primary Hyperoxaluria Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Primary Hyperoxaluria Drug in 2023
Figure 80. Manufacturing Process Analysis of Primary Hyperoxaluria Drug
Figure 81. Primary Hyperoxaluria Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
